SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-068299
Filing Date
2021-05-17
Accepted
2021-05-17 17:15:49
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nwbo-20210331x10q.htm   iXBRL 10-Q 1316261
2 EXHIBIT 31.1 nwbo-20210331xex31d1.htm EX-31.1 12261
3 EXHIBIT 32.1 nwbo-20210331xex32d1.htm EX-32.1 8571
  Complete submission text file 0001104659-21-068299.txt   6212287

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20210331.xsd EX-101.SCH 47907
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20210331_cal.xml EX-101.CAL 45014
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20210331_def.xml EX-101.DEF 136592
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20210331_lab.xml EX-101.LAB 331647
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20210331_pre.xml EX-101.PRE 277019
9 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20210331x10q_htm.xml XML 1353938
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 21932342
SIC: 2834 Pharmaceutical Preparations